GB552619A - Improvements relating to bactericidal substances - Google Patents

Improvements relating to bactericidal substances

Info

Publication number
GB552619A
GB552619A GB1324241A GB1324241A GB552619A GB 552619 A GB552619 A GB 552619A GB 1324241 A GB1324241 A GB 1324241A GB 1324241 A GB1324241 A GB 1324241A GB 552619 A GB552619 A GB 552619A
Authority
GB
United Kingdom
Prior art keywords
medium
growth
days
glucose
strain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1324241A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boots Pure Drug Co Ltd
Original Assignee
Boots Pure Drug Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Pure Drug Co Ltd filed Critical Boots Pure Drug Co Ltd
Priority to GB1324241A priority Critical patent/GB552619A/en
Publication of GB552619A publication Critical patent/GB552619A/en
Expired legal-status Critical Current

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

552,619. Bactericidal substances. BOOTS PURE DRUG CO., Ltd., COULTHARD, C. E., MICHAELIS, R., and SHORT, W. F. Oct. 14, 1941. No. 13242. [Class 81 (i)] A bacteriostatic substance, denoted in the Specification as penicillin A, is obtained from a culture on a suitable medium (e.g. a solution of glucose containing small proportions of sodium nitrates, potassium phosphate and chloride, magnesium sulphate and ferrous sulphate), of a strain of Penicillium notatum capable of maintaining an acid PH in a glucose medium during growth and of producing an active agent insoluble or slightly soluble in usual organic solvents. The strain of penicillin is selected by trial and error to obtain colonies having the stated growth characteristics and product. A culture medium as described above is inoculated with a selected strain grown for about 14 days on the same medium. The PH of the medium at the beginning of growth is about 6.5 and falls after 3-4 days to about 3.5 at which it remains until the completion of growth in about 8-14 days. The liquor, from which most of the glucose has disappeared, is decanted and filtered and may be stored with the addition of chloroform as a preservative. To isolate the active substance the liquor may be concentrated, by evaporation under reduced pressure, or by freezing out, and the substance precipitated with an organic solvent, preferably acetone. Purification is effected by solution in water and reprecipitation. Reference is made in the Specification to the literature including the Lancet 1941.2, page 177.
GB1324241A 1941-10-14 1941-10-14 Improvements relating to bactericidal substances Expired GB552619A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1324241A GB552619A (en) 1941-10-14 1941-10-14 Improvements relating to bactericidal substances

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1324241A GB552619A (en) 1941-10-14 1941-10-14 Improvements relating to bactericidal substances

Publications (1)

Publication Number Publication Date
GB552619A true GB552619A (en) 1943-04-16

Family

ID=10019408

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1324241A Expired GB552619A (en) 1941-10-14 1941-10-14 Improvements relating to bactericidal substances

Country Status (1)

Country Link
GB (1) GB552619A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2416821A (en) * 1941-10-14 1947-03-04 Therapeutic Res Corp Of Great Bacteriostatic substances
US2476287A (en) * 1944-06-03 1949-07-19 Celanese Corp Method for producing watersoluble leuco vat dyestuff
US2519902A (en) * 1949-01-27 1950-08-22 Haller Grace Process for forming penicillin solution

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2416821A (en) * 1941-10-14 1947-03-04 Therapeutic Res Corp Of Great Bacteriostatic substances
US2476287A (en) * 1944-06-03 1949-07-19 Celanese Corp Method for producing watersoluble leuco vat dyestuff
US2519902A (en) * 1949-01-27 1950-08-22 Haller Grace Process for forming penicillin solution

Similar Documents

Publication Publication Date Title
Chain et al. An antibacterial substance produced by Penicillium claviforme
Brian et al. The production of viridin by pigment‐forming strains of Trichoderma viride
GB1226589A (en)
GB783611A (en) Gibberellic acid and derivatives thereof
GB1003546A (en) The manufacture and use of a carotenoid
GB1272769A (en) Improvements in or relating to cephalosporin derivatives
Berger et al. Dehydrogenases of the Avena coleoptile
US2423873A (en) Method for production of increased yields of penicillin
GB1398591A (en) Process for growing a fungus
O'Callaghan et al. The formation of metabolites from cephalosporin compounds
GB552619A (en) Improvements relating to bactericidal substances
Dixon Excystment of metacercariae of Fasciola hepatica L. in vitro
Munk et al. Glucose oxidase of Aspergillus niger: I. Factors influencing glucose oxidase activity in submerged cultivation of Aspergillus niger on synthetic medium
Mizuno et al. Studies on starter metabolism. IV. Effect of various substrates on the formation of acetoin by a mixed strain starter culture
Murayama et al. Fragin, a New Biologically Active Metabolite of a Pseudomonas: Part I. Isolation, Characterization and Biological Activities
McKee et al. An Antibiotic Substance Produced by Submerged Cultivation of Aspergillus flavus.
US2695261A (en) Production of polymyxins a, b, and e
GB683423A (en) Improvements in and relating to antibiotic substances produced by group n streptococcus lactis
DE2240052C3 (en) Process for the production of citric acid by submerged fermentation
ASTRUP et al. Protein Metabolism of Tissue Cells in vitro
Bernheim et al. Effect of β-propiolactone on Metabolism of Pseudomonas aeruginosa and Growth of Certain Fungi
GB1131079A (en) The antibiotic armentomycin
GB672510A (en) Improvements in or relating to the purification of aureomycin
SU1713529A1 (en) Solution for embryos extraction
US2443962A (en) Method of producing antibiotic substance